Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 65, No 3 (2014)
Review paper
Submitted: 2014-06-27
Accepted: 2014-06-27
Published online: 2014-06-27
View PDF Download PDF file View HTML
Get Citation

The role of fat mass and obesity-associated gene (FTO) in obesity — an overview

Aleksandra Zdrojowy-Wełna, Małgorzata Tupikowska, Katarzyna Kolackov, Grażyna Bednarek-Tupikowska
DOI: 10.5603/EP.2014.0031
·
Endokrynol Pol 2014;65(3):224-231.

open access

Vol 65, No 3 (2014)
Review Article
Submitted: 2014-06-27
Accepted: 2014-06-27
Published online: 2014-06-27

Abstract

Obesity is an epidemic of the 21st century. The magnitude of this problem stems from its increasing prevalence and numerous metabolic complications caused by excessive fat accumulation. The pathogenesis involves both environmental and genetic factors, and FTO (fat massand obesity-associated gene) is one of the most significant among genes predisposing to obesity. The role of FTO polymorphism in the development of obesity has been confirmed in many studies, but the effect varies significantly in different ethnic groups. Moreover, the exact mechanisms of FTO influence are yet to be explained. The association between FTO and lifestyle factors such as diet and physical activity has been extensively studied in recent years. This paper presents current knowledge about the role of FTO gene in the development of obesity and type 2 diabetes in different ethnic groups and the association between FTO polymorphism and lifestyle modifications predisposing to adiposity.

Abstract

Obesity is an epidemic of the 21st century. The magnitude of this problem stems from its increasing prevalence and numerous metabolic complications caused by excessive fat accumulation. The pathogenesis involves both environmental and genetic factors, and FTO (fat massand obesity-associated gene) is one of the most significant among genes predisposing to obesity. The role of FTO polymorphism in the development of obesity has been confirmed in many studies, but the effect varies significantly in different ethnic groups. Moreover, the exact mechanisms of FTO influence are yet to be explained. The association between FTO and lifestyle factors such as diet and physical activity has been extensively studied in recent years. This paper presents current knowledge about the role of FTO gene in the development of obesity and type 2 diabetes in different ethnic groups and the association between FTO polymorphism and lifestyle modifications predisposing to adiposity.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

obesity; fat mass and obesity-associated gene; polymorphism; ethnicity; lifestyle modifications

About this article
Title

The role of fat mass and obesity-associated gene (FTO) in obesity — an overview

Journal

Endokrynologia Polska

Issue

Vol 65, No 3 (2014)

Article type

Review paper

Pages

224-231

Published online

2014-06-27

Page views

3525

Article views/downloads

4932

DOI

10.5603/EP.2014.0031

Bibliographic record

Endokrynol Pol 2014;65(3):224-231.

Keywords

obesity
fat mass and obesity-associated gene
polymorphism
ethnicity
lifestyle modifications

Authors

Aleksandra Zdrojowy-Wełna
Małgorzata Tupikowska
Katarzyna Kolackov
Grażyna Bednarek-Tupikowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl